 Press Release Distribution |
 |
Filter News Show All ResultsNews By Country
News By Tag Chi  Related Tags Bioinformatics
Cancer Clinical Clinical Conference Clinical Trials Drug Design Drug Discovery Energy Fda GHD Immunogenicity Informatics Mk4 Mk5 Nih Pharma Conference Pharmaceutical Conference Pharmaceutical Conferences R D Tai
| chi News+ XML/RSSBy Cambridge Healthtech Institute In silico Lead Finding through Holistic Understanding of Screening Data from Multiple Approaches By Cambridge Healthtech Institute Cambridge Healthtech Institute & Bio-IT World organizes a dinner short course on June 6, 2012 at the Royal Sonesta Hotel Boston in Cambridge, MA. The course will be held at the conclusion of day one of the Structure-Based Drug Design conference. By Cambridge Healthtech Institute Hear breakthroughs in the field of pathology such as predictive cancer biomarkers, decoding cancer molecular profiles, next generation sequencing, circulating tumor cells, etc. View final agenda at www.healthtech.com/tdx. More than 100 Leading Organizations to Convene in San Francisco Next Month for R&D Informatics Event By Cambridge Healthtech Institute 100+ pharma and biotech companies from around the world will participate at CHI's 4th annual Integrated R&D Informatics & Knowledge Management conference to be held in San Francisco, CA on February 21-23, 2012. By Cambridge Healthtech Institute Badri Rengarajan, M.D., Medical Director, will present in the modeling and simulation tools to improve Phase III success session. By Cambridge Healthtech Institute Dr. Quackenbush will present in the translating biomarker driven cancer treatments into practice session. By Cambridge Healthtech Institute Dr. Leach will participate in a keynote session at this conference scheduled for Feb. 21-23, 2012, San Francisco, CA. The conference is organized by Cambridge Healthtech Institute. By Cambridge Healthtech Institute Dr. Craig Jordan announces presentation at upcoming symposium on February 19-20, 2012 in San Francisco, CA. CHI Releases Pre-Registrant List for its 4th Integrated R&D Informatics & Knowledge Management Event By Cambridge Healthtech Institute This conference is part of the Molecular Med TRI-CON 2012 event on February 21-23, 2012 at the Moscone North Convention Center in San Francisco, CA. Advance registration discounts ends on January 13. By Cambridge Healthtech Institute Dr. Williams will present on evidentiary standards for surrogate endpoints, genetic testing & CDx. Cambridge Healthtech Institute Announces its Inaugural Bioinformatics & Cancerinformatics Conference By Cambridge Healthtech Institute CHI’s Bioinformatics & Cancerinformatics conference is a new program being held at the Molecular Med TRI-CON 2012 on Feb. 21-23 at the Moscone in San Francisco. This conference is part of the many program options available at the Tri-Conference. By Cambridge Healthtech Institute Amarin’s CMO to lead line-up of thought leaders at Cambridge Healthtech Institute’s executive and scientific forum. By Hannah Shapiro Incredibly priced deals guaranteed--just in time for the holidays. By Cambridge healthtech Institute CHI confirms new speakers for its keynote session on cancer clinical trials in the era of personalized medicine lead by Roche Holding AG, UCSF Helen Diller Family Comprehensive Cancer Center, and Samuel Oschin Comprehensive Cancer Institute. By Cambridge Healthtech Institute Cambridge Healthtech Institute just adds an interactive panel discussion to take place at its Integrated R&D Informatics & Knowledge Management conference on Feb. 21-23, 2012, San Francisco, CA. By Cambridge Healthtech Institute Cambridge Healthtech Institute’s (CHI) BioPharma Strategy Series is proud to present the first conference on Phase III Clinical Trials: Strategic Decisions for Successful Drugs to be held in Philadelphia, PA on March 12-13, 2012. By Cambridge Healthtech Institute When: November 17-18, 2011 Where: Omni Parker House - Boston, MA By Cambridge Healthtech Institute CHI’s Oncology Clinical Trials conference will highlight two case studies by Seattle Genetics’ Eric Sievers, M.D., Vice President, Clinical Affairs, and Elaine S. Waller, Pharm.D., M.B.A., Senior Vice President, Regulatory Affairs. By Cambridge Healthtech Institute CHI’s Oncology Clinical Trials conference will highlight three Zelboraf case studies by Genentech, F. Hoffmann-La Roche, and Roche Molecular Systems. This conference is part of the many program options available at the Tri-Conference. By Cambridge Healthtech Institute CHI’s Integrated R&D Informatics conference will once again be held at the Molecular Med TRI-CON 2012 on Feb. 21-23, 2012 at the Moscone in San Francisco, CA. This conference is part of the many program options available at the Tri-Conference. All Press ReleasesBy Cambridge Healthtech Institute This event will take place prior to the start of the Next Generation Dx Summit: Moving Assays to Clinic (August 21-23). By Cambridge Healthtech Institute In silico Lead Finding through Holistic Understanding of Screening Data from Multiple Approaches By Cambridge Healthtech Institute This session is the latest addition to CHI’s Tissue-Based Diagnostics Conference, June 4-5, 2012, Philadelphia, PA. Hear a keynote presentation by Guillermo Tearney, M.D., Ph.D., Prof. of Pathology, Harvard Medical School & Mass General Hospital. By Cambridge Healthtech Institute Dr. Copeland will present in the druggability and kinetics-based drug design session. By Cambridge Healthtech Institute Those that missed last month's event can get a CD with 80 speaker presentations from 4 pipelines: formulation, purification, biotherapeutics, and expression. Individual track CDs and the overall event CD is available at CHI-PepTalk.com. By Cambridge Healthtech Institute Cambridge Healthtech Institute & Bio-IT World organizes a two hour dinner short course on June 7, 2012, Royal Sonesta Hotel Boston, Cambridge, MA. The course will be held at the conclusion of day two of the Structure-Based Drug Design conference. By Cambridge Healthtech Institute Cambridge Healthtech Institute & Bio-IT World organizes a dinner short course on June 6, 2012 at the Royal Sonesta Hotel Boston in Cambridge, MA. The course will be held at the conclusion of day one of the Structure-Based Drug Design conference. By Cambridge Healthtech Institute Hear breakthroughs in the field of pathology such as predictive cancer biomarkers, decoding cancer molecular profiles, next generation sequencing, circulating tumor cells, etc. View final agenda at www.healthtech.com/tdx. More than 100 Leading Organizations to Convene in San Francisco Next Month for R&D Informatics Event By Cambridge Healthtech Institute 100+ pharma and biotech companies from around the world will participate at CHI's 4th annual Integrated R&D Informatics & Knowledge Management conference to be held in San Francisco, CA on February 21-23, 2012. By Cambridge Healthtech Institute Badri Rengarajan, M.D., Medical Director, will present in the modeling and simulation tools to improve Phase III success session. By Cambridge Healthtech Institute Dr. Quackenbush will present in the translating biomarker driven cancer treatments into practice session. By Cambridge Healthtech Institute Dr. Leach will participate in a keynote session at this conference scheduled for Feb. 21-23, 2012, San Francisco, CA. The conference is organized by Cambridge Healthtech Institute. By Cambridge Healthtech Institute Chris Porter, Product Manager, HPC Cloud, will lead a luncheon presentation at CHI’s Cloud Computing: Applications and Advances in Life Sciences R&D Symposium next month in San Francisco, CA. By Cambridge Healthtech Institute Dr. Craig Jordan announces presentation at upcoming symposium on February 19-20, 2012 in San Francisco, CA. CHI Releases Pre-Registrant List for its 4th Integrated R&D Informatics & Knowledge Management Event By Cambridge Healthtech Institute This conference is part of the Molecular Med TRI-CON 2012 event on February 21-23, 2012 at the Moscone North Convention Center in San Francisco, CA. Advance registration discounts ends on January 13. By Cambridge Healthtech Institute Dr. Williams will present on evidentiary standards for surrogate endpoints, genetic testing & CDx. Cambridge Healthtech Institute Announces its Inaugural Bioinformatics & Cancerinformatics Conference By Cambridge Healthtech Institute CHI’s Bioinformatics & Cancerinformatics conference is a new program being held at the Molecular Med TRI-CON 2012 on Feb. 21-23 at the Moscone in San Francisco. This conference is part of the many program options available at the Tri-Conference. By Cambridge Healthtech Institute Amarin’s CMO to lead line-up of thought leaders at Cambridge Healthtech Institute’s executive and scientific forum. By Hannah Shapiro Incredibly priced deals guaranteed--just in time for the holidays. By Cambridge healthtech Institute CHI confirms new speakers for its keynote session on cancer clinical trials in the era of personalized medicine lead by Roche Holding AG, UCSF Helen Diller Family Comprehensive Cancer Center, and Samuel Oschin Comprehensive Cancer Institute. By Cambridge Healthtech Institute Cambridge Healthtech Institute just adds an interactive panel discussion to take place at its Integrated R&D Informatics & Knowledge Management conference on Feb. 21-23, 2012, San Francisco, CA. By Cambridge Healthtech Institute Cambridge Healthtech Institute’s (CHI) BioPharma Strategy Series is proud to present the first conference on Phase III Clinical Trials: Strategic Decisions for Successful Drugs to be held in Philadelphia, PA on March 12-13, 2012. By Cambridge Healthtech Institute When: November 17-18, 2011 Where: Omni Parker House - Boston, MA By Cambridge Healthtech Institute CHI’s Oncology Clinical Trials conference will highlight two case studies by Seattle Genetics’ Eric Sievers, M.D., Vice President, Clinical Affairs, and Elaine S. Waller, Pharm.D., M.B.A., Senior Vice President, Regulatory Affairs. By Cambridge Healthtech Institute CHI’s Oncology Clinical Trials conference will highlight three Zelboraf case studies by Genentech, F. Hoffmann-La Roche, and Roche Molecular Systems. This conference is part of the many program options available at the Tri-Conference. By Cambridge Healthtech Institute CHI’s Integrated R&D Informatics conference will once again be held at the Molecular Med TRI-CON 2012 on Feb. 21-23, 2012 at the Moscone in San Francisco, CA. This conference is part of the many program options available at the Tri-Conference. By Adelphi University, Kali Chan Adelphi has officially launched the CHI, a cornerstone of the University’s comprehensive strategic plan. The Center seeks to tackle and improve current and emerging healthcare needs and make Adelphi an even stronger thought leader in healthcare. By Cambridge Healthtech Institute CHI’s Oncology Clinical Trials: Bringing Targeted & Tailored Cancer Therapy will take place on Feb. 21-23, 2012 at the Moscone in San Francisco, CA. This conference is part of the many program options available at the Molecular Med TRI-CON 2012. By Cambridge Healthtech Institute Christopher P. Austin, M.D., Scientific Director, NIH Center for Translational Therapeutics, will deliver the keynote presentation at CHI’s Predictive Functional Human Tissue Models conference scheduled on November 17-18, 2011, Boston, MA. By Cambridge Healthtech Institute Cambridge Healthtech Institute (CHI) is pleased to offer this pre-conference short course on Tuesday, November 15 at the DoubleTree Hotel in Bethesda, MD. By Cambridge Healthtech Institute Delegates now have the option to choose from 9 moderated breakout discussion groups at this conference that is set for October 3-4, 2011, Cambridge, MA (part of CHI's Barnett Clinical Summit: Optimizing Trial Management). By Cambridge Healthtech Institute Cambridge Healthtech Institute announces three sponsors and presenters at upcoming conference set for November 3-5, 2011 in Philadelphia: Biovista, Cetero Research, and Lotus Clinical Research, LLC. By Cambridge Healthtech Institute 3 hour course to be held in Boston on November 17 lead by David Kaplan, Ph.D., Tufts University; Melik Demirel, Ph.D., Pennsylvania University; Derek J. Hansford, Ph.D., Ohio State University; and Umut A. Gurkan, Ph.D., Harvard-MIT. By Cambridge Healthtech Institute Early registration discounts (up to $400 off a conference registration) will be offered until August 26. By Cambridge Healthtech Institute This summit (part of CHI's Third Annual Immunogenicity Summit) is scheduled for November 17-18, 2011 at the DoubleTree Hotel in Bethesda, MD. By Cambridge Healthtech Institute This year’s theme is about moving into the third dimension of drug discovery and development. This conference will take place on November 17-18, 2011 in Boston, MA. Early registration discounts will be offered until August 26. By Cambridge Healthtech Institute This summit (part of CHI's Third Annual Immunogenicity Summit) is scheduled for November 16-17, 2011 at the DoubleTree Hotel in Bethesda, MD. By Cambridge Healthtech Institute CHI/Barnett International to hold 3 hour course on October 3, 2011 at the Boston Cambridge Marriott in Cambridge, MA, as part of its Barnett Clinical Summit: Optimizing Trial Management - www.BarnettClinicalSummit.com By Cambridge Healthtech Institute 3 hour course to be held in Philadelphia on October 3, 2011, by John Arrowsmith, Ph.D., Science Director, Europe, Thomson Life Sciences Consulting & Richard K. Harrison, Ph.D., Scientific Director, North America, Thomson Life Sciences Consulting By Cambridge Healthtech Institute A 2-part event covering developments in assay technologies, risk assessment, regulatory guidance and means of predicting and avoiding immunogenicity. Early registration discounts will be offered until August 26. By Cambridge Healthtech Institute Cambridge Healthtech Institute and Barnett International today announced that its Inaugural Site Performance conference will be part of its Barnett Clinical Summit: Optimizing Trial Management. By Cambridge Healthtech Institute Cambridge Healthtech Institute and Barnett International today announced that its Inaugural Clinical Protocol Optimization conference will be part of its Barnett Clinical Summit: Optimizing Trial Management. By Cambridge Healthtech Institute Cambridge Healthtech Institute will be hosting the 2nd Annual Companion Diagnostics as an Integral Part of Personalized Medicine Conference in Washington, DC on August 24-25, 2011. This conference is part of CHI’s Next Generation Dx Summit. By Cambridge Healthtech Institute This conference will take place on Aug. 16-17, 2011, Cambridge, MA. Experts from vaccine manufacturers, suppliers, quality control, and platform development gather to learn new technologies & advance the field of vaccine & therapeutic manufacturing. By Cambridge Healthtech Institute Today, Inovio Pharmaceuticals reports long-term immune responses from therapeutic cervical dysplasia and cancer DNA vaccine. Mark Bagarazzi, M.D., Chief Medical Officer, will speak at CHI's Clinical Development of Vaccines conference. By Cambridge Healthtech Institute CHI and Bio-IT World's "Structure-Based Design" Conference to be held on June 8-10, 2011 in Cambridge, MA, will feature a new session: New Targets and Drug Modalities By Cambridge Healthtech Institute CHI and Bio-IT World's "Structure-Based Design" Conference to be held on June 8-10, 2011 in Cambridge, MA, will feature a new session: Fragment-Based Drug Design By Cambridge Healthtech Institute Featuring 12 conference programs within 4 streams focused on the current trends and science in antibody engineering and development (PEGSummit.com). By Sun Born Natural Products Company Sun Born Natural Products Company’s Herbal Chi Balm gains more ground in professional sports By Insight Pharma Reports New report available at InsightPharmaReports.com | ||||||||||||||||||||||
Like PRLog?
3.5K1.4K1.3K